Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics report positive topline data from 8 mg dose of phase 2 obesity trial of GLP-1/GIP receptor dual agonist HRS9531
Microbial Safety: Sterility, Microbial Limits, and Preservative Efficacy Nasal drug products interface with the nasal mucosa a highly vascularized, immunologically active tissue adjacent to the sinuses and upper respiratory tract
However, as we age, as well as dealing with chronic stress, environmental toxins, poor diet, infections and metabolic dysfunction our immune system can become compromised and your body is left susceptible to disease
Mild and temporary reactions like redness or discomfort at the site of injection have been reported
Comprised of three amino acids, this potent ingredient is used topically to support healthy skin ageing, promoting smoothness and brightness to minimise the look of deep lines